N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide

C35H52N2O4 — CID 163875539

IUPACN-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide
SMILESCC(=O)N(Cc1ccccn1)CC1C[C@@H](C)[C@H]2C(O1)[C@H](O)[C@@]1(C)C3CC[C@H]4C(C)(C)[C@@H](O)CCC45C[C@@]35CC[C@]21C
InChIInChI=1S/C35H52N2O4/c1-21-17-24(19-37(22(2)38)18-23-9-7-8-16-36-23)41-29-28(21)32(5)14-15-35-20-34(35)13-12-27(39)31(3,4)25(34)10-11-26(35)33(32,6)30(29)40/h7-9,16,21,24-30,39-40H,10-15,17-20H2,1-6H3/t21-,24?,25+,26?,27+,28+,29?,30+,32-,33-,34?,35+/m1/s1
InChIKeyPONKGOOEAFXLDA-IMPALVOCSA-N
MW564.81 g/mol
LogP5.60
Rot. Bonds4

About N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide

N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide (PubChem CID 163875539) has the molecular formula C35H52N2O4 and a molecular weight of 564.81 g/mol. Its IUPAC name is N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide.

Molecular Properties

Compound NameN-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide
PubChem CID163875539
Molecular FormulaC35H52N2O4
Molecular Weight564.81 g/mol
Exact Mass564.39
IUPAC NameN-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide
SMILESCC(=O)N(Cc1ccccn1)CC1C[C@@H](C)[C@H]2C(O1)[C@H](O)[C@@]1(C)C3CC[C@H]4C(C)(C)[C@@H](O)CCC45C[C@@]35CC[C@]21C
InChIInChI=1S/C35H52N2O4/c1-21-17-24(19-37(22(2)38)18-23-9-7-8-16-36-23)41-29-28(21)32(5)14-15-35-20-34(35)13-12-27(39)31(3,4)25(34)10-11-26(35)33(32,6)30(29)40/h7-9,16,21,24-30,39-40H,10-15,17-20H2,1-6H3/t21-,24?,25+,26?,27+,28+,29?,30+,32-,33-,34?,35+/m1/s1
InChIKeyPONKGOOEAFXLDA-IMPALVOCSA-N
XLogP5.60
TPSA82.89 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms41
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500564.81
LogP ≤ 55.60
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide?
The IUPAC name of N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide (CID 163875539) is N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide.
What is the SMILES notation for N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide?
The canonical SMILES for N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide is CC(=O)N(Cc1ccccn1)CC1C[C@@H](C)[C@H]2C(O1)[C@H](O)[C@@]1(C)C3CC[C@H]4C(C)(C)[C@@H](O)CCC45C[C@@]35CC[C@]21C.
What is the InChIKey of N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide?
The InChIKey is PONKGOOEAFXLDA-IMPALVOCSA-N. The full InChI is InChI=1S/C35H52N2O4/c1-21-17-24(19-37(22(2)38)18-23-9-7-8-16-36-23)41-29-28(21)32(5)14-15-35-20-34(35)13-12-27(39)31(3,4)25(34)10-11-26(35)33(32,6)30(29)40/h7-9,16,21,24-30,39-40H,10-15,17-20H2,1-6H3/t21-,24?,25+,26?,27+,28+,29?,30+,32-,33-,34?,35+/m1/s1.
What are the key properties of N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide?
N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide has a molecular weight of 564.81 g/mol, XLogP of 5.60, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[(1S,4R,5R,6R,11R,12S,16R,18S)-11,18-dihydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]methyl]-N-(pyridin-2-ylmethyl)acetamide is sourced from PubChem (CID 163875539), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).